In 2021, Polpharma launched a comprehensive investment program for further development of active substances, which includes, among other things, the construction of a plant for the production of highly potent APIs. One of the milestones of the adopted strategy is the commissioning of a new kilo-scale development and production laboratory (“Kilo Lab”). Filled with the latest technology, the facility enables the production of the most advanced substances in Poland.
Read more